Body Fluid Spaces and Blood Pressure in Hemodialysis Patients During Amelioration of Anemia With Erythropoietin-Reference-Cited by-同舟云学术

Body Fluid Spaces and Blood Pressure in Hemodialysis Patients During Amelioration of Anemia With Erythropoietin

Published:1990-11 Issue:5 Volume:16 Page:438-446
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Abraham Paul A.,Opsahl John A.,Keshaviah Prakash R.,Collins Allan J.,Whalen John J.,Asinger Richard W.,McLain Lori A.,Hanson Ginger,Davis Marcia G.,Halstenson Charles E.

Publisher

Elsevier BV

Subject

Nephrology

Reference45 articles.

1. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic hemodialysis;Winearls;Lancet,1986

2. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin;Eschbach;N Engl J Med,1987

3. Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having hemodialysis;Casati;Br Med J,1987

4. The effect of recombinant human erythropoietin (EPO) upon quality of life (QL) and functional capacity (FC) of uremic patients on chronic hemodialysis;Keown;Kidney Int,1989

5. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin;Evans RW Rader;JAMA,1990

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of erythropoiesis-stimulating agents on systolic and diastolic blood pressure in hemodialysis patients: A systematic review and meta-analysis of clinical trials;Medicina Clínica;2024-05

2. The effect of erythropoiesis-stimulating agents on systolic and diastolic blood pressure in hemodialysis patients: A systematic review and meta-analysis of clinical trials;Medicina Clínica (English Edition);2024-05

3. Erythropoietin and Its Cardiovascular Effects;Cardio-Nephrology;2017

4. The Safety of Erythropoiesis-Stimulating Agents for the Treatment of Anemia Resulting from Chronic Kidney Disease;Clinical Drug Investigation;2016-02-19

5. Hypoxia-Inducible Factor Stabilizers: a New Avenue for Reducing BP While Helping Hemoglobin?;Current Hypertension Reports;2016-02-19